Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
TETRAHYDROIMIDAZO[1,5-D][1,4]OXAZEPINE DERIVATIVE
Document Type and Number:
WIPO Patent Application WO/2014/133022
Kind Code:
A1
Abstract:
A compound represented by general formula (I) [wherein R represents a hydrogen atom, a C1-6 alkyl group or the like; R1 represents a C1-6 alkyl group, a C1-6 alkoxy group or the like; R2 represents a halogen atom, a C1-6 alkyl group, a C1-6 alkoxy group or the like; R3 represents a hydrogen atom, a C1-6 alkyl group or the like; and R4 represents a C1-6 alkyl group or the like] or a pharmaceutically acceptable salt thereof, which is an antagonist of mGluR2 and can be used as a therapeutic agent for neurological disorders associated with mGluR2-associated glutamate dysfunction and diseases, such as Alzheimer's disease.

Inventors:
TAKAISHI MAMORU (JP)
SATO NOBUHIRO (JP)
SHIBUGUCHI TOMOYUKI (JP)
MOTOKI TAKAFUMI (JP)
TAKAHASHI YOSHINORI (JP)
SASAKI TAKEO (JP)
BRAUNTON ALAN (GB)
Application Number:
PCT/JP2014/054724
Publication Date:
September 04, 2014
Filing Date:
February 26, 2014
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
EISAI R&D MAN CO LTD (JP)
International Classes:
C07D498/04; A61K31/553; A61P25/28
Domestic Patent References:
WO2010068520A22010-06-17
WO2007139149A12007-12-06
Foreign References:
JP2009510011A2009-03-12
JP2012510437A2012-05-10
JP2008534455A2008-08-28
JP2012513399A2012-06-14
Other References:
SCIENCE, vol. 258, 1992, pages 597 - 603
TRENDS PHARMACOL. SCI., vol. 14, 1993, pages 13
NEUROPHARMACOL., vol. 46, no. 7, 2004, pages 907 - 917
PHARMACOL. THERAPEUTICS, vol. 104, no. 3, 2004, pages 233 - 244
NEUROPHARMACOL., vol. 66, 2013, pages 40 - 52
J. MASS SPECTRUM. SOC. JPN., vol. 51, no. 5, 2003, pages 492 - 498
See also references of EP 2963043A4
Attorney, Agent or Firm:
HASEGAWA Yoshiki et al. (JP)
Yoshiki Hasegawa (JP)
Download PDF: